MEDcraze Raises $3M in Seed Financing

MEDcraze LLC, an Atlanta, GA-based online platform startup that provides patient information and access to new medical technologies, completed a £3m seed funding round.
This financing has been made exclusively by JG Griffeth Investments LLC.

The company will use the proceeds to make key hires and continue to build out additional platform features, expand advertising efforts and opportunities for medical device, biotech and pharmaceutical companies that have recently launched new products.

Led by Carey Markey, Founder and CEO, and Manny Trujillo MD, Plastic Surgeon and Co-Founder, MEDcraze is an online community which allows recently diagnosed patients with an upcoming surgical procedure to obtain access to applicable advancements in medical technology. They can then take this information and have an elevated discussion, based on technology, with their healthcare provider.

Source. FinSMEs, May 4, 2020

This post was brought to you by Woewoda Communications, your partner in the Canadian startup market; offering strategic communications & public relations services to Canadian startups involved in ICT, IoT, blockchain, life sciences, healthcare, agribusiness, clean energy, fintech, AI and robotics.

Are you a pre-seed to late stage funded Canadian startup that needs to grow or scale? Give us a call! One of our representatives would love to explain how we vertically design, and then systematically layer each of our communication platforms to effectively reach niche target audiences for our clients. WC offers a unique synergistic approach to effectively communicate our client's message to their target audience.

LightIntegra Raises USD$5.3M in Series A Funding

LightIntegra Technology, a Vancouver, BC-based developer of a 5-minute test for platelet activation status, received $5.3m in Series A funding.

The round was led by Genome BC and Boardwalk Ventures Inc. and includes funding from Tower Beach Capital Ltd., Coleco Investments, and Quimby Investments (VCC) Ltd.

The company intends to use the funds to bring its test to the US market.

Led by William Dubiel, President and CEO, LightIntegra Technology has advanced ThromboLUX, a non-invasive, rapid optical test that assesses platelet activation status, which does not require dilution. As a routine test for platelet concentrates, it identifies which platelet units may be best suited for prophylaxis and which units may be best suited for therapeutic use.

The medical diagnostics company launched from the Canadian Blood Services R&D labs through the efforts of research scientist Dr. Elisabeth Maurer.

Source. FinSMEs, Staff, April 24, 2019

***

This post was brought to you by Woewoda Communications, your partner in the Canadian private equity and startup markets; offering strategic communications, public relations & investor relation services to Canadian VCs, PEs, Angels, Endowments/Trusts, Family Offices, and Canadian startups involved in ICT, IoT, blockchain, life sciences, healthcare, agribusiness, clean energy, fintech, AI and robotics.

Are you a Canadian startup that needs to grow or scale? Give us a call! One of our representatives would love to explain how we vertically design, and then systematically layer each of our communication platforms to effectively reach niche target audiences for our clients. WC offers a unique synergistic approach to effectively communicate our client's message to their target audience.

Serving Vancouver, Montreal, Toronto, Waterloo, Ottawa, and Halifax.